Virginia asks Fourth Circuit to stay order blocking parts of its unauthorized-vape sales law

Jan.21
Virginia asks Fourth Circuit to stay order blocking parts of its unauthorized-vape sales law
Virginia has asked the U.S. Court of Appeals for the Fourth Circuit to stay a district court order that blocks enforcement of certain provisions of a state law restricting the sale of unauthorized vaping products. The district court held the law was preempted to the extent it enforced federal requirements under the FDCA and the Tobacco Control Act.

Key points

 

• Virginia filed a motion in the Fourth Circuit seeking a stay pending appeal

• A district court order partially blocked enforcement, finding preemption under the FDCA and TCA in part

• Virginia argues the statutes allow stricter state sales regulation and do not require state rules to differ from federal law

• Virginia says its law is an independent measure and can exclude products even if FDA-authorized when state registration steps are unmet

• Virginia challenges plaintiffs’ standing and claims irreparable public health harm without a stay

 


 

2Firsts, January 21, 2026

 

According to Law360, the Commonwealth of Virginia is asking the U.S. Court of Appeals for the Fourth Circuit to stay a district court order that blocks enforcement of certain aspects of a state law restricting the sale of unauthorized vaping products.

 

The report says Virginia filed a motion on Friday arguing the district court was wrong to conclude the law is preempted by the federal Food, Drug and Cosmetic Act (FDCA) and the Family Smoking Prevention and Tobacco Control Act (TCA). Virginia contends those statutes expressly allow states to impose stricter regulations on the sale of tobacco products and do not require state laws to be different from federal requirements. The state also describes the district court’s approach as an outlier compared with other jurisdictions that have rejected the same premise.

 

The dispute follows an order by U.S. District Judge David J. Novak that partially granted a request by Nova Distro Inc. and Tobacco Hut and Vape Fairfax Inc. to block enforcement of some provisions, finding preemption to the extent the state law was enforcing federal law.

 

Virginia argues that preemption requires a conflict between state and federal law, and that a state law incorporating and running parallel to federal standards does not create such a conflict. The state further argues the district court misread the TCA, and that the TCA’s savings clause covering state laws involving the sale or distribution of tobacco products contains no requirement that state rules must be different. Virginia says the district court’s view produces “anomalous” results, including allowing states to ban all e-cigarettes — even FDA-authorized ones — while preventing states from coordinating with federal oversight.

 

The report also notes Virginia’s position that its law is a separate measure rather than an impermissible attempt to enforce the FDCA, pointing out that even FDA-authorized products may be excluded if a manufacturer has not completed state registration steps.

 

Virginia additionally argues the plaintiffs lack standing because they have no legally protected interest in selling products that are already illegal under federal law, and that the plaintiffs are not challenging the validity of that federal law. The state says it will suffer irreparable harm to its ability to protect public health absent a stay, and that the balance of equities favors the state because the products at issue are illegal under federal law.

 

Image source: Law360

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Sued Over Allowing Some Unauthorized Vapes and Nicotine Pouches to Stay on Market
FDA Sued Over Allowing Some Unauthorized Vapes and Nicotine Pouches to Stay on Market
Public health groups, pediatricians and parents sued the U.S. Food and Drug Administration on July 14, 2026, challenging a May enforcement guidance that they say allows unauthorized e-cigarettes and nicotine pouches to remain on the market while applications are under review.
Jul.15
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12
Indiana’s Foreign-Made Vape Ban Takes Effect, Forcing Brands and Retailers to Adjust Supply Chains
Indiana’s Foreign-Made Vape Ban Takes Effect, Forcing Brands and Retailers to Adjust Supply Chains
A new Indiana law restricting the sale of foreign-made vape products has taken effect, requiring retailers to adjust inventory and sourcing practices. According to The Sun, WDRB and other reports, some local vape shops are reviewing product origins and supplier information to comply with the new requirements. The measure represents a broader shift in U.S. vape regulation, with oversight expanding beyond product authorization and sales rules toward manufacturing origin and supply-chain management.
Jul.24
Product | Republic Technologies Launches ZIG Nicotine Pouches, Expanding Beyond Traditional Tobacco Accessories
Product | Republic Technologies Launches ZIG Nicotine Pouches, Expanding Beyond Traditional Tobacco Accessories
Republic Technologies UK has entered the nicotine pouch market with ZIG Nicotine Pouches, marking the company’s expansion beyond traditional tobacco-related accessories into smoke-free nicotine products. The product is expected to enter UK retail channels from August 2026, including convenience stores, supermarkets and tobacco retailers. The launch includes six flavors and three nicotine strengths: 8mg, 12mg and 17mg.
Market
Jul.21 by 2Firsts Perspectives
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
Philip Morris Japan (PMJ) announced that it will open “IQOS Flagship Ginza” in Tokyo on September 4, 2026. The location will become the first global flagship space for PMI’s IQOS brand. PMJ said the venue will target adult smokers aged 20 and above and combine product experiences, community engagement and local cultural elements. The design will incorporate Japanese natural aesthetics and traditional craftsmanship. The launch reflects PMI’s broader strategy of strengthening consumer engagement through experiential retail and brand spaces. The existing IQOS Store Ginza is scheduled to close on August 30, 2026.
Jul.21
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24